1. American College of Rheumatology, Hotline (2005) The safety of COX-2 inhibitors. Deliberations from the February 16–18, 2005, FDA Meeting.
http://www.rheumatology.org/publications/hotline/0305COX2.asp?aud+mem
. Accessed 16 Jan 2007
2. Antman EM, Bennett JS, Daugherty A, Furberg C, Roberts H, Taubert KA (2007a) Use of nonsteroidal anti-inflammatory drugs. An update for clinicians. Circulation 115:1634–1642
3. Antman EM, Bennett JS, Daugherty A, Furberg C, Roberts H, Taubert KA, American Heart Association (2007b) Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation 115:1634–1642
4. Armstrong PCJ, Truss NJ, Ali FY, Dhanji AA, Vojnovic I et al (2008) Aspirin and the in vitro linear relationship between thromboxane A2-mediated platelet aggregation and platelet production on thromboxane A2. J Thromb Haemost 6:1933–1943
5. Assous N, Touzé E, Meune C, Kahan A, Alloanore Y (2007) Cardiovascular disease in rheumatoid arthritis: single center hospital based cohort in France. Joint Bone Spine 74(1):66–72